SITE-DIRECTED MUTAGENESIS OF HUMAN MYELOPEROXIDASE - FURTHER IDENTIFICATION OF RESIDUES INVOLVED IN CATALYTIC ACTIVITY AND HEME INTERACTION

被引:22
|
作者
JACQUET, A [1 ]
GARCIAQUINTANA, L [1 ]
DELEERSNYDER, V [1 ]
FENNA, R [1 ]
BOLLEN, A [1 ]
MOGUILEVSKY, N [1 ]
机构
[1] UNIV MIAMI,SCH MED,DEPT BIOCHEM & MOLEC BIOL,MIAMI,FL 33101
关键词
D O I
10.1006/bbrc.1994.1895
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Evidence for the involvement of four spatially clustered residues, Asp268(94), His261(95), Glu408(242) and Met409(243), in catalytic and spectral properties of human myeloperoxidase was provided by the analysis of site-directed mutants wherein these amino acids have been substituted by asparagine, alanine, glutamine and glutamine respectively. Although none of the mutations prevented folding, heme incorporation or secretion of the enzyme from transfected Chinese Hamster Ovary cell lines, the G1u488(242) to Gin and the Met409(243) to Gin substitutions led to a full blue-shift of the Sorer peak, whereas the Asp268(94) to Asn modification led to a partial blue-shift. On the other hand, His261(95)->Ala and Met409(243)->Gln mutants totally lost the typical peroxidasic activity of the enzyme, whereas the Asp268(94)->Asn mutant was only partially active. These results confirm that His261(95) is the distal histidine essential for the catalytic activity of the enzyme while Asp268(94), Met409(243) and G1u488(242) are necessary for maintaining the correct conformation of the active site and all four residues that interact closely with the periphery of the heme contribute to the unique spectral properties of the heme in MPO. (C) 1994 Academic Press, Inc.
引用
收藏
页码:73 / 81
页数:9
相关论文
共 50 条
  • [1] Identification of essential amino acid residues for catalytic activity and thermostability of novel chitosanase by site-directed mutagenesis
    Yoon, HG
    Kim, HY
    Lim, YH
    Kim, HK
    Shin, DH
    Hong, BS
    Cho, HY
    APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2001, 56 (1-2) : 173 - 180
  • [2] Identification of essential amino acid residues for catalytic activity and thermostability of novel chitosanase by site-directed mutagenesis
    H.-G. Yoon
    H.-Y. Kim
    Y.-H. Lim
    H.-K. Kim
    D.-H. Shin
    B.-S. Hong
    H.-Y. Cho
    Applied Microbiology and Biotechnology, 2001, 56 : 173 - 180
  • [3] Identification of residues involved in v-Src substrate recognition by site-directed mutagenesis
    Yokoyama, N
    Miller, WT
    FEBS LETTERS, 1999, 456 (03) : 403 - 408
  • [4] Site-directed mutagenesis of rabbit proacrosin - Identification of residues involved in zona pellucida binding
    Richardson, RT
    ORand, MG
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (39) : 24069 - 24074
  • [5] SITE-DIRECTED MUTAGENESIS OF THE HEME CREVICE RESIDUES OF CYTOCHROME-C
    KOSHY, TI
    LUNTZ, TL
    SCHEJTER, A
    GARBER, EAE
    MARGOLIASH, E
    FASEB JOURNAL, 1988, 2 (04): : A585 - A585
  • [6] ANALYSIS OF THE CATALYTIC ACTIVITY OF HUMAN FACTOR XIIIA BY SITE-DIRECTED MUTAGENESIS
    HETTASCH, JM
    GREENBERG, CS
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1994, 269 (45) : 28309 - 28313
  • [7] Inhibition of the catalytic activity of human transaldolase by antibodies and site-directed mutagenesis
    Banki, K
    Perl, A
    FEBS LETTERS, 1996, 378 (02): : 161 - 165
  • [8] IDENTIFICATION OF RESIDUES INVOLVED IN NUCLEOTIDYLTRANSFERASE ACTIVITY OF JHP933 FROM HELICOBACTER PYLORI BY SITE-DIRECTED MUTAGENESIS
    Ye, Xianren
    Zhao, Yanhe
    Wu, Xiuling
    Su, Yintao
    Wu, Yunkun
    She, Feifei
    ARCHIVES OF BIOLOGICAL SCIENCES, 2016, 68 (02) : 439 - 444
  • [9] Identification by site-directed mutagenesis of residues involved in ligand recognition and activation of the human A3 adenosine receptor
    Gao, ZG
    Chen, A
    Barak, D
    Kim, SK
    Müller, CE
    Jacobson, KA
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (21) : 19056 - 19063
  • [10] Identification by site-directed mutagenesis of residues involved in ligand recognition and activation of human A3 adenosine receptors
    Gaul, ZG
    Chen, A
    Barak, D
    Kim, SK
    Müller, CF
    Jacobson, KA
    DRUG DEVELOPMENT RESEARCH, 2002, 56 (04) : 566 - 566